Insights

Just as all of us were grateful to leave 2020 in the rear-view mirror, 2021 makes us realize that, at least for now, only the calendar appears to have changed. With the current post-holiday spike in new Covid-19 cases likely moving to new highs, the darkest part of the Coronavirus winter is underway with job growth slowing and consumer spending softening as this fast-spreading virus increases the likelihood of further economic disruption…

The fourth quarter was another positive quarter for domestic equities. The S&P 500 Index returned 12.2%, the Russell 1000 Value Index gained 16.3% and the Coho Relative Value Equity portfolio advanced 10.7%. There was a clear cyclical tilt to the quarter, as Energy, Financial Services, and Industrials lead the advance while Consumer Staples and Health Care were among the laggards…

After a 37-year career that includes years of dedicated service to Coho Partners, Brian Kramp, Portfolio Manager and Director of Research, is setting his sights on a well-deserved retirement.

Brian has been a valued member of the Investment Team and has helped shape Coho’s culture for nearly 15 years. He made important contributions to the firm and our clients in his role on the Board of Directors, as a portfolio manager, investment analyst, and thought leader…

The abuse of opioid drugs has taken a heavy toll on public health over the past 20 years. The addiction to and overdoses from opioids have resulted in tens of thousands of deaths in the U.S. From manufacturers to retailers, the entire pharmaceutical value chain is being held responsible for contributing to the opioid crisis. This exposes the relevant companies to both financial and social risks that investors should carefully monitor and manage…